Bulk Pharmaceutical API Sources for PEPCID

Bulk Pharmaceutical API Sources for PEPCID

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		F6889_SIGMA
TCI (Tokyo Chemical Industry)		F0530
Molport		MolPort-002-557-620
Molport		MolPort-003-941-395
Hangzhou APIChem Technology		AC-11713

Bulk API Sources for PEPCID

Last updated: February 26, 2026

Pepcid (famotidine) is an H2 receptor antagonist used to treat conditions like gastric ulcers, GERD, and Zollinger-Ellison syndrome. The active pharmaceutical ingredient (API), famotidine, is sourced globally from multiple manufacturers, primarily located in Asia, Europe, and North America.

Major API Manufacturers for Famotidine

Manufacturer	Country	Certifications	Production Capacity	Key Clients
Jiangsu Huifeng Pharmaceutical	China	GMP, ISO 9001, ISO 14001	Estimated 100 metric tons annually	Major generic companies worldwide
Zhejiang NHU Co., Ltd.	China	GMP, ISO 9001, ISO 14001	Approx. 80 metric tons annually	Global generics and API suppliers
Euticals S.p.A.	Italy	GMP, ISO 9001	Limited, specialized production	European pharmaceutical companies
LGM Pharma	United States	cGMP compliant	Custom manufacturing; capacity varies	Contract manufacturing organizations (CMOs)
Zhejiang Tianxing Pharmaceutical	China	GMP	50+ metric tons annually	Global generics market

Sources Distribution by Region

1. Asia-Pacific: Dominates API production, particularly China and India, accounting for over 80% of global API manufacturing capacity for famotidine. Chinese plants hold most approvals for WHO-GMP and FDA inspections for famotidine.

2. Europe: European producers mainly serve the European Union, with plants in Italy, Germany, and Spain. They focus on high-quality, certified APIs, often for antimicrobial, specialty, or high-margin formulations.

3. North America: US-based firms like LGM Pharma focus on custom or specialty API production, often for niche or high-value markets.

Quality and Certification Standards

Standard	Description	Frequency of Inspection
GMP	Good Manufacturing Practice	Ongoing, with inspections every 1-3 years, depending on the jurisdiction
ISO 9001	Quality management systems	Annually recertified
ISO 14001	Environmental management	Triennial recertification

Most reputable API suppliers maintain compliance with these standards, with suppliers in China increasingly acquiring US and EU certifications to access global markets.

Supply Chain Considerations

• Raw Material Security: Most API manufacturers extract raw materials locally, reducing geopolitical risks but subject to local regulatory changes.
• Regulatory Approvals: Suppliers with prior US FDA or EMA approval facilitate smoother registration and market entry.
• Capacity Constraints: API shortages have been reported, especially during the COVID-19 pandemic; capacity expansions and vertical integration reduce supply-risk.

Regulatory and Export Policies

• Chinese API producers operate under the Drug Administration Law, with export licenses necessary for international trade.
• US and European producers face specific import/export documentation, emphasizing compliance with standards like US FDA's Drug Master File (DMF) and EMA certification.
• The US embargo on certain Chinese API exports has intermittently impacted supply, requiring manufacturers to diversify supply sources.

Trends Influencing API Sourcing

• Vertical Integration: Some pharmaceutical companies acquire API manufacturing infrastructure to ensure supply stability.
• API Price Volatility: Periodic raw material shortages and demand surges cause price fluctuations.
• Environmental Constraints: New environmental regulations in China have prompted some API manufacturers to upgrade or relocate capacity.

Conclusion

The API for PEPCID (famotidine) primarily comes from Chinese producers, with additional supplies from European and North American manufacturers. Quality certifications and compliance standards vary, influencing market access and pricing. Supply chain security depends on diversification, regulatory compliance, and capacity management.

---

Key Takeaways

• Most famotidine APIs are produced in China, with European and US suppliers catering to niche markets.
• Chinese API manufacturers hold bulk capacity, but increasing environmental regulations are impacting production.
• Certifications like GMP, ISO 9001, and ISO 14001 are vital, especially for export to regulated markets.
• Supply chain disruptions have historically affected API availability, emphasizing the need for diversified sourcing.
• US and European suppliers often focus on high-standard API production, supporting compliance with global regulations.

---

FAQs

1. Which countries dominate famotidine API production?
China leads, followed by European countries like Italy and Germany, and North American manufacturers in the US.

2. How secure is the supply of famotidine API?
Supply security depends on supplier capacity, diversification, and regulatory compliance. Disruptions have occurred during global events like COVID-19.

3. What certifications should buyers prioritize?
Good Manufacturing Practice (GMP), ISO 9001, and ISO 14001 are critical for global market access and quality assurance.

4. Are there regional differences in API quality?
Yes. European and US suppliers typically have higher certification standards, but Chinese API producers have significantly improved quality controls.

5. How do environmental regulations affect API production?
Stricter environmental regulations in China have led to capacity adjustments, plant upgrades, and potential shifts in sourcing strategies.

---

References

[1] U.S. Food and Drug Administration. (2022). Drug Master Files.
[2] European Medicines Agency. (2022). API Certification Standards.
[3] China Food and Drug Administration. (2021). API Manufacturing Regulations.
[4] LGM Pharma. (2023). API Sourcing and Supply Chain.
[5] Zhejiang NHU Co., Ltd. Annual Report. (2022).